CHEMO PHARMA LABORATORIES LTD. - 506365 - Disclosure of Voting results of AGM (Regulation 44(3) of SEBI (LODR) Regulations, 2015)
Chemo Pharma Laboratories Ltd has informed BSE regarding the details of Voting results of AGM, under Regulation 44(3) of SEBI (LODR) Regulations, 2015. Kindly Click here CHEMO PHARMA LABORATORIES LTD. - 506365 - Shareholder Meeting / Postal Ballot-Scrutinizer''s Report
Pursuant to regulation 44(3) of SEBI (Listing Obligations and Disclosure Requirements), 2015, we submit herewith the details regarding the voting results of the business transacted at the 78th Annual General Meeting (AGM) of the Members of the Company held on Tuesday, September 29, 2020 at 04.00 p.m., through video conferencing / Other Audio Visual Means. We also enclose the consolidated report of the scrutinizer on remote e-voting and e-voting at the AGM. CHEMO PHARMA LABORATORIES LTD. - 506365 - Closure of Trading Window
Intimation of Closure of Trading Window for the quarter ended 30.09.2020 CHEMO PHARMA LABORATORIES LTD. - 506365 - Shareholder Meeting / Postal Ballot-Outcome of AGM
Disclosure of events pursuant to Regulation 30(2) Schedule III - Part A - A (13) of SEBI (Listing Regulations & Disclosure Requirements), 2015 - Summary of the Proceedings of the Seventy Eight Annual General Meeting held on September 29, 2020 CHEMO PHARMA LABORATORIES LTD. - 506365 - Reg. 34 (1) Annual Report
Submission of Annual Report for the financial year 2019-2020 as per Regulation 34 of SEBI(LODR), 2015 CHEMO PHARMA LABORATORIES LTD. - 506365 - Intimation Of Book Closure And Record Date For The Annual General Meeting (AGM) Of The Company, Which Is Going To Be Held On Tuesday, 29Th September, 2020 Through Video Conferencing ('VC') / Other Audio Visual Means ('OAVM') At 04:00 P.M.
Dear Sirs, This is to inform you that Register of Members (Share Transfer Book) will be closed pursuant to the Regulation 42 (2) to (4) of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 in connection to the Annual General Meeting (AGM) of the Company, which is going to be held on Tuesday, 29th September, 2020 through Video Conferencing ('VC') / Other Audio Visual Means ('OAVM') at 04:00 p.m., details of dates are as follows - 1. Book Closure Date -24th September, 2020 to 29th September, 2020 (both days inclusive) 2. Record Date -22nd September, 2020 You are requested to take this on your records. CHEMO PHARMA LABORATORIES LTD. - 506365 - Submission Of Un-Audited Financial Results For The Quarter Ended 30.06.2020
Submission of Un-Audited Financial Results for the quarter ended 30.06.2020 CHEMO PHARMA LABORATORIES LTD. - 506365 - Submission Of Outcome Of Board Meeting Held On 18.08.2020
Submission of Outcome of Board Meeting held on 18.08.2020 CHEMO PHARMA LABORATORIES LTD. - 506365 - Revision of Board Meeting
Purpose of the meeting has been revised CHEMO PHARMA LABORATORIES LTD. - 506365 - Board Meeting Intimation for Intimation Of Board Meeting To Be Held On Tuesday, 18Th August, 2020 At 04:00 P.M. To Consider And Approve Un-Audited Financial Results For The Quarter Ended 30.06.2020
CHEMO PHARMA LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 18/08/2020 ,inter alia, to consider and approve Dear Sirs, This is to inform you that the Meeting of the Board of Directors of the Company will be held on Tuesday, 18th August, 2020 at 04:00 p.m. to transact the following business: 1.To consider and approve the Un-Audited Financial Results for the quarter ended 30th June, 2020. 2.To place and take on record the Limited Review Report on Un-Audited Financial Results for the quarter ended 30th June, 2020. 3.To decide and convene Annual General Meeting of the Company on Wednesday, 29th August, 2020 at 04:00 p.m. through VC/OAVM and to approve Notice of Annual General Meeting. 4.To decide to fix the Book Closure date from 24th September, 2020 to 29th September, 2020 (both days inclusive) and record date on 22nd September, 2020. 5.To appoint HS Associates, Practicing Company Secretaries to act as a Scrutinizer for the forthcoming Annual General Meeting of the Company for the financial year 2019-2020.